11 July 2024
DR. MARTENS
PLC
RESULT OF ANNUAL GENERAL
MEETING
11 JULY
2024
The Company announces the results of
voting at its Annual General Meeting held earlier today and
confirms that all resolutions were duly passed on a poll with
majorities as set out below.
Resolutions 1 to 16 were proposed as
Ordinary Resolutions and resolutions 17 to 20 as Special
Resolutions.
|
Resolution
|
Votes
For
(note 1)
|
%
|
Votes
Against
(note 1)
|
%
|
Votes
Total
|
Votes
Withheld
(note 2)
|
% Voting
Capital
Instructed
|
|
01
|
Receive the 2024 Annual Report and
Accounts
|
789,653,948
|
99.87%
|
1,016,107
|
0.13%
|
790,670,055
|
389,119
|
82.18
|
|
02
|
Approve the Directors' Remuneration
Report
|
784,551,256
|
99.18%
|
6,479,754
|
0.82%
|
791,031,010
|
28,164
|
82.22
|
|
03
|
Approve the Remuneration
Policy
|
784,540,438
|
99.18%
|
6,484,634
|
0.82%
|
791,025,072
|
34,102
|
82.22
|
|
04
|
Approve the Final
Dividend
|
790,899,254
|
99.98%
|
138,398
|
0.02%
|
791,037,652
|
21,522
|
82.22
|
|
05
|
Elect Giles Wilson
|
790,575,687
|
99.94%
|
472,252
|
0.06%
|
791,047,939
|
11,235
|
82.22
|
|
06
|
Re-elect Paul Mason
|
739,380,746
|
98.45%
|
11,649,105
|
1.55%
|
751,029,851
|
40,029,322
|
78.06
|
|
07
|
Re-elect Kenny Wilson
|
782,546,350
|
99.38%
|
4,857,639
|
0.62%
|
787,403,989
|
3,655,185
|
81.84
|
|
08
|
Re-elect Andrew Harrison
|
784,035,245
|
99.11%
|
7,011,325
|
0.89%
|
791,046,586
|
12,587
|
82.22
|
|
09
|
Re-elect Ian Rogers
|
784,033,188
|
99.11%
|
7,013,122
|
0.89%
|
791,046,586
|
12,587
|
82.22
|
|
10
|
Re-elect Lynne Weedall
|
782,969,980
|
98.98%
|
8,079,606
|
1.02%
|
791,049,586
|
9,587
|
82.22
|
|
11
|
Re-elect Robyn Perriss
|
783,169,527
|
99.00%
|
7,880,059
|
1.00%
|
791,049,586
|
9,587
|
82.22
|
|
12
|
Re-elect Tara Alhadeff
|
775,890,657
|
98.53%
|
11,583,929
|
1.47%
|
787,474,586
|
3,584,587
|
81.85
|
|
13
|
Re-appoint PricewaterhouseCoopers
LLP as auditor
|
790,431,574
|
99.92%
|
619,491
|
0.08%
|
791,051,065
|
8,109
|
82.22
|
|
14
|
Authorise the Audit & Risk
Committee to determine the Auditor's remuneration
|
790,886,095
|
99.98%
|
160,465
|
0.02%
|
791,046,560
|
12,614
|
82.22
|
|
15
|
Authorise the Company and its
subsidiaries to make political donations
|
782,418,912
|
99.36%
|
5,046,388
|
0.64%
|
787,465,300
|
3,593,874
|
81.85
|
|
16
|
Authorise allotment of
shares
|
781,095,005
|
99.30%
|
5,488,607
|
0.70%
|
786,583,612
|
4,475,562
|
81.76
|
|
17
|
Authorise general disapplication of
pre-emption rights*
|
744,775,869
|
94.58%
|
42,685,045
|
5.42%
|
787,460,914
|
3,598,260
|
81.85
|
|
18
|
Authorise additional disapplication
of pre-emption rights*
|
743,752,064
|
94.45%
|
43,708,850
|
5.55%
|
787,460,914
|
3,598,260
|
81.85
|
|
19
|
Authorise purchase of own
shares*
|
772,052,557
|
97.61%
|
18,934,341
|
2.39%
|
790,986,898
|
72,276
|
82.22
|
|
20
|
Authorise calling of general
meetings on 14 days' notice*
|
788,373,014
|
99.66%
|
2,680,102
|
0.34%
|
791,053,116
|
6,058
|
82.22
|
*Special Resolution
The votes of independent shareholders
on the resolutions concerning the election or re-election of the
Independent Non-Executive Directors are set out below:
|
Resolution
|
Votes
For
|
%
|
Votes
Against
|
%
|
Votes
Total
|
Votes
Withheld
|
%
Independent
Capital
Instructed
|
|
08
|
Re-elect Andrew Harrison
|
414,092,821
|
98.34%
|
7,011,325
|
1.66%
|
421,104,146
|
12,587
|
71.12%
|
|
09
|
Re-elect Ian Rogers
|
414,091,024
|
98.33%
|
7,013,122
|
1.67%
|
421,104,146
|
12,587
|
71.12%
|
|
10
|
Re-elect Lynne Weedall
|
413,027,540
|
98.08%
|
8,079,606
|
1.92%
|
421,107,146
|
9,587
|
71.13%
|
|
11
|
Re-elect Robyn Perriss
|
413,227,087
|
98.13%
|
7,880,059
|
1.87%
|
421,107,146
|
9,587
|
71.13%
|
Notes:
1. Votes
"For" and "Against" are expressed as a percentage of votes
received.
2. A "Vote withheld" is
not a vote in law and is not counted in the calculation of the
votes "For" or "Against" a resolution.
3. As at 6.30pm on 9
July 2024 the Company had a total of 962,080,090 ordinary shares
with voting rights in issue. The total independent voting capital,
used to calculate the votes of independent shareholders on
resolutions 8 to 11, was 592,062,882.
4. In
accordance with Listing Rule 9.6.2R, copies of the resolutions
passed as special business will shortly be available for inspection
on the National Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
Enquiries
Company Secretariat
Paul Rolling, Assistant Company
Secretary
+44 7584 243562
Investors and analysts
Bethany Barnes, Director of Investor
Relations
+44 7825 187465
bethany.barnes@drmartens.com
Media
Gill Hammond, Director of
Communications
+44 7384
214248
H/Advisors Maitland
+44 20 7379 5151
Katharine Spence
+44 7384 535739
About Dr. Martens
Dr. Martens is an iconic British
brand founded in 1960 in Northamptonshire. Produced originally for
workers looking for tough, durable boots, the brand was quickly
adopted by diverse youth subcultures and associated musical
movements. Dr. Martens has since transcended its working-class
roots while still celebrating its proud heritage and, six decades
later, "Docs" or "DM's" are worn by people around the world who use
them as a symbol of empowerment and their own individual attitude.
The Company is a constituent of the FTSE 250 index.
